Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ALAB | MPWR |
|---|---|---|
| Price | $352.86 | $1,442.13 |
| Change today | ▼ 1.00% | ▲ 5.96% |
| Market cap | $61.22B | $70.87B |
| Return, 3 months | -13.2% | +12.0% |
| Return, year to date | +112.1% | +59.7% |
| Return, 1 year | +68.3% | +55.8% |
| P/E (TTM) | 173.8 | 88.0 |
| P/B | 35.5 | 18.2 |
| P/E percentile vs own 5y | 72nd | 59th |
| Dividend yield | – | 0.49% |
| Revenue growth (YoY, latest qtr) | +104.5% | +47.6% |
| Net profit growth (YoY) | +198.9% | +90.6% |
| Gross margin | 75.1% | 55.2% |
| Operating margin | 22.8% | 28.7% |
| Net margin | 30.7% | 24.5% |
| Return on equity | 25.8% | 22.0% |
| Analyst target vs. price | +18.1% | +27.4% |
| Analyst buy share | 75% | 90% |
| RSI (14) | 61 | 59 |
| 30-day volatility | 82.3% | 45.3% |
| Max drawdown, 1 year | -59.1% | -32.3% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
